GlassScriptPhysician profile
Benjamin M Taylor
NPI 1356929152
$547.09
in general payments reported to CMS, 2019-2025
21 companies · $407 in 2025
The $407 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $28.91 · 2024: $111 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $65.18 | 2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $48.00 | 2024-2025 | |
| Almatica Pharma LLC | $35.85 | 2024-2025 | Loreev Xr |
| Glaxosmithkline, LLC. | $34.72 | 2025 | Trelegy Ellipta, Shingrix, Bexsero |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $32.63 | 2025 | Caplyta |
| Phathom Pharmaceuticals, INC. | $32.37 | 2025 | Voquezna |
| Lilly USA, LLC | $29.43 | 2025 | Zepbound, Mounjaro |
| Silk Road Medical, INC. | $28.91 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Sanofi-Aventis U.S. LLC | $24.57 | 2024 | |
| Tris Pharma INC | $23.92 | 2025 | Dyanavel Xr |
| Neurocrine Biosciences, INC. | $21.98 | 2025 | |
| Corium, LLC | $20.62 | 2025 | Azstarys |
| Janssen Biotech, INC. | $20.43 | 2024 | Erleada |
| Teva Pharmaceuticals USA, INC. | $17.56 | 2025 | Uzedy |
| Ironshore Pharmaceuticals INC. | $17.10 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $16.94 | 2025 | Veozah |
| Vanda Pharmaceuticals INC. | $16.84 | 2025 | Fanapt |
| Novo Nordisk INC | $16.56 | 2025 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $14.81 | 2025 | Airsupra |
| Exact Sciences Corporation | $14.78 | 2024 | Cologuard Collection Kit |
| Collegium Pharmaceutical, INC. | $13.89 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.